A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial. (Q38429571)
Jump to navigation
Jump to search
scientific article published on 26 October 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial. |
scientific article published on 26 October 2007 |
Statements
A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial (English)
Christopher W Lee
Karl BĂ©langer
Sanjay C Rao
Teresa M Petrella
Richard G Tozer
Lori Wood
Kerry J Savage
Elizabeth A Eisenhauer
Nancy Wainman
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference